The Latest Headlines at American Banking and Market News
UWM (NYSE:UWMC) Earns “Market Perform” Rating from Keefe, Bruyette & Woods
Keefe, Bruyette & Woods reiterated their market perform rating on shares of UWM (NYSE:UWMC – Free Report) in a report issued on Friday morning, Benzinga reports. They currently have a $7.00 target price on the stock, up... More of this article »
Fate Therapeutics (NASDAQ:FATE) Price Target Cut to $4.00 by Analysts at Piper Sandler
Fate Therapeutics (NASDAQ:FATE – Free Report) had its target price decreased by Piper Sandler from $7.00 to $4.00 in a research note published on Friday, Benzinga reports. Piper Sandler currently has a neutral rating on the biopharmaceutical... More of this article »
Insulet (NASDAQ:PODD) Price Target Increased to $260.00 by Analysts at Jefferies Financial Group
Insulet (NASDAQ:PODD – Free Report) had its target price increased by Jefferies Financial Group from $255.00 to $260.00 in a research report sent to investors on Friday morning, Benzinga reports. They currently have a buy rating... More of this article »
Piper Sandler Lowers Savers Value Village (NYSE:SVV) Price Target to $19.00
Savers Value Village (NYSE:SVV – Free Report) had its target price decreased by Piper Sandler from $24.00 to $19.00 in a research note issued to investors on Friday, Benzinga reports. Piper Sandler currently has an overweight... More of this article »
Wedbush Reiterates “Outperform” Rating for Guild (NYSE:GHLD)
Wedbush reiterated their outperform rating on shares of Guild (NYSE:GHLD – Free Report) in a research report report published on Friday morning, Benzinga reports. They currently have a $17.00 target price on the stock. Several... More of this article »
UWM (NYSE:UWMC) Rating Reiterated by Wedbush
Wedbush restated their neutral rating on shares of UWM (NYSE:UWMC – Free Report) in a research report sent to investors on Friday, Benzinga reports. They currently have a $7.00 price objective on the stock. Separately, Keefe,... More of this article »
Beauty Health (NASDAQ:SKIN) PT Lowered to $2.50 at Piper Sandler
Beauty Health (NASDAQ:SKIN – Free Report) had its price target trimmed by Piper Sandler from $3.00 to $2.50 in a research note published on Friday, Benzinga reports. The firm currently has an underweight rating on the stock. SKIN... More of this article »
Jefferies Financial Group Initiates Coverage on Ferrari (NYSE:RACE)
Jefferies Financial Group assumed coverage on shares of Ferrari (NYSE:RACE – Free Report) in a research note issued to investors on Friday morning, MarketBeat Ratings reports. The firm issued a hold rating and a $403.00 target... More of this article »
Liberty Latin America (NASDAQ:LILAK) PT Raised to $18.00
Liberty Latin America (NASDAQ:LILAK – Free Report) had its target price upped by Pivotal Research from $17.00 to $18.00 in a research note published on Friday, Benzinga reports. They currently have a buy rating on the stock. Separately,... More of this article »
Needham & Company LLC Reiterates “Hold” Rating for Amicus Therapeutics (NASDAQ:FOLD)
Needham & Company LLC restated their hold rating on shares of Amicus Therapeutics (NASDAQ:FOLD – Free Report) in a research note issued to investors on Friday, Benzinga reports. Other research analysts have also issued... More of this article »
Needham & Company LLC Increases MKS Instruments (NASDAQ:MKSI) Price Target to $145.00
MKS Instruments (NASDAQ:MKSI – Free Report) had its target price upped by Needham & Company LLC from $125.00 to $145.00 in a report issued on Friday morning, Benzinga reports. They currently have a buy rating on the scientific... More of this article »
Accelerate Diagnostics (NASDAQ:AXDX) Shares Cross Below 200-Day Moving Average of $2.52
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.52 and traded as low as $0.89. Accelerate Diagnostics... More of this article »
Keefe, Bruyette & Woods Reiterates “Market Perform” Rating for Brookfield (NYSE:BN)
Keefe, Bruyette & Woods reiterated their market perform rating on shares of Brookfield (NYSE:BN – Free Report) in a report published on Friday morning, Benzinga reports. Keefe, Bruyette & Woods currently has a $46.00... More of this article »